Suwon, South Korea

Byung Goo Lee



 

Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Suwon-si, KR (2015)
  • Suwon, KR (2015 - 2016)

Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Byung Goo Lee: Innovator in Pharmaceutical Chemistry

Introduction

Byung Goo Lee is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel antibiotics and crystalline forms of pharmaceutical compounds. With a total of 3 patents, his work has had a meaningful impact on the industry.

Latest Patents

One of his latest patents is a method for preparing meropenem using zinc powder. This invention relates to an improved method for synthesizing meropenem trihydrate, a novel carbapenem antibiotic. Another significant patent involves the crystal forms of adefovir dipivoxil and processes for preparing the same. This invention presents novel forms A, B, C, D, E, F, and G of crystalline 9-[2-[phosphonomethoxy]ethyl]adenine bis-pivaloyloxymethyl ester, which can be obtained with high purity through a simple method and in high yield.

Career Highlights

Throughout his career, Byung Goo Lee has worked with prominent companies in the pharmaceutical sector, including Daewoong Pharmaceutical Co., Ltd. and Daewoong Bio Inc. His expertise in pharmaceutical chemistry has allowed him to contribute to various innovative projects and advancements in drug development.

Collaborations

He has collaborated with several professionals in his field, including Soo Jin Choi and Hee Kyoon Yoon. These collaborations have further enhanced his research and development efforts.

Conclusion

Byung Goo Lee's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the industry. His work continues to influence the development of important pharmaceutical compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…